VitaNova Life Sciences Corp

What they do

The company develops, acquires, markets and sells branded nutritional supplements, functional beverages and complementary lifestyle products, with substantially all operations conducted through wholly owned subsidiary NutriPeak Trading Corporation since November 2023. It operates under a B2B model with regional distributors and channel partners, relying on online channels including Douyin Cross-border, Weidian Cross-border and U.S. direct-to-consumer sales. Production, packaging and fulfillment are outsourced to third-party contract manufacturers and logistics partners. During the year ended April 30, 2026, it also began selling healthy food products such as olive juice, white sesame oil and aloe vera drink.

Revenue drivers

• Healthy food products — The newer line, sold through VitaNova Global Foods Corporation, generated $234,576 of the $321,576 total revenue in the quarter ended July 31, 2026, making it the larger segment.
• Dietary supplement products — Sold through NutriPeak Trading Corporation, this line generated $87,000 of revenue in the quarter ended July 31, 2026.
• B2B distributor and channel partner sales — Revenue is primarily generated through regional distributors and channel partners that use online traffic channels including Douyin Cross-border, Weidian Cross-border and U.S. direct-to-consumer sales.

Recent performance

For the quarter ended July 31, 2026, revenue was $321,576, up 210% from $103,899 in the prior-year quarter. Cost of revenue was $291,055, leaving gross profit of $30,521, down from $68,781 a year earlier. Operating expenses were $152,683, producing a loss from operations of $122,162 and a net loss of $123,101, compared with a net loss of $46,301 in the prior-year quarter. For fiscal 2026, revenue was $3.0M with a net loss of $37,304, while operating cash flow was $814,407. At July 31, 2026, the company reported total assets of $2.2M, total liabilities of $311,656, shareholder equity of $1.9M and cash and equivalents of $1.6M.

Strategy

The company describes an asset-light operating model in which product strategy, formulation oversight, brand management and regulatory compliance are handled internally while production, packaging and fulfillment are outsourced. Its dietary supplement operations run through a dual-brand structure consisting of GeneCode, positioned as a science-oriented wellness line, and AMZ, positioned for high-volume functional nutrition. It is pursuing B2B expansion through regional distributors and online channels including Douyin Cross-border, Weidian Cross-border and U.S. direct-to-consumer sales. The company formed VitaNova Global Foods Corporation in March 2026 for healthy food products and World Q Corporation in June 2026 for raw materials used in dietary supplements, though World Q had no operations as of the latest report. It also completed a 1-for-3 reverse stock split and a name change to VitaNova Life Sciences Corporation in January 2026.

Risks

• Customer and channel concentration — Revenue depends on a limited set of regional distributors and channel partners, including Douyin Cross-border, Weidian Cross-border and U.S. direct-to-consumer channels.
• Gross margin compression — In the quarter ended July 31, 2026, cost of revenue of $291,055 consumed most of $321,576 in revenue, cutting gross profit to $30,521 from $68,781 a year earlier.
• Reliance on third-party manufacturers — The asset-light model outsources production, packaging and fulfillment to contract manufacturers and logistics partners, leaving quality and supply timing outside direct control.
• Product and segment concentration — The newer healthy food line produced $234,576 of $321,576 in quarterly revenue, so results are heavily tied to a product category launched only in the year ended April 30, 2026.

Outlook

The company has not provided specific financial guidance in the excerpts. Management states it is expanding the healthy food products line and building new subsidiaries, including World Q Corporation for dietary supplement raw materials. It continues to emphasize B2B distributor relationships and online channels for market penetration. The latest quarter showed revenue growth but also a widening net loss and lower gross profit, which management attributes to the fast growth of the new healthy food products line.